Biallelic Variant, c.644‐13_644‐9del in <scp><i>UNC50</i></scp> Is Associated With Congenital Myasthenia Syndrome
UNC50 encodes a transmembrane protein that plays a crucial role in L-acetylcholine receptor trafficking and thus cholinergic transmission at the neuromuscular junction. Previously, a biallelic loss-of-function variant in UNC50 was reported in an individual with lethal arthrogryposis multiplex congenita. We herein describe affected individuals from two unrelated families with arthrogryposis multiplex congenita in one family and a severe early-onset neuromuscular dysfunction in the other, both within the spectrum of congenital myasthenia syndrome. A biallelic variant, c.644-13_644-9del, p.? in intron 5 of UNC50 (NM_014044.7) was identified in both families. Transcript analysis in the peripheral blood cDNA of the heterozygous carrier parents of family 1 revealed that the c.644-13_644-9del variant leads to aberrant splicing. With these findings, we validated the association of disease-causing variants in UNC50 with congenital myasthenia syndrome.
Authors
- Mangalore S. Shravya
- Katta M. Girisha
- Anju Shukla (ORCID: https://orcid.org/0000-0003-2471-4094)
- Periyasamy Radhakrishnan (ORCID: https://orcid.org/0000-0002-7690-3201)
- Gandham SriLakshmi Bhavani (ORCID: https://orcid.org/0000-0001-5284-8909)
- Mary Mathew
- Shruti Bajaj (ORCID: https://orcid.org/0000-0002-8754-2229)
- Greeshma Purushothama (ORCID: https://orcid.org/0000-0003-0753-7508)
- Shalini S. Nayak (ORCID: https://orcid.org/0000-0001-9521-7031)
- Malavika Hebbar (ORCID: https://orcid.org/0000-0001-9527-9726)
- Shyamala Guruvare (ORCID: https://orcid.org/0000-0001-7933-2400)
Institutions
- Manipal Academy of Higher Education (IN)
- Sultan Qaboos University (OM)
- Kasturba Medical College, Manipal (IN)
Publication Details
- Journal
- American Journal of Medical Genetics Part A
- Published
- 2025-04-12
- DOI
- https://doi.org/10.1002/ajmg.a.64086
- Citations
- 2
- Primary Topic
- Cellular transport and secretion
- Type
- article
- Field-Weighted Citation Impact
- 2.30
Funders
- Wellcome Trust
- Department of Biotechnology, Ministry of Science and Technology, India
- The Wellcome Trust DBT India Alliance
- National Institutes of Health